久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • First patient dosed for Phase I/II trial of avapritinib in advanced GIST biospectrumasia
    August 26, 2019
    CStone announces on a registrational bridging study in China which includes a Phase I dose-escalation study and Phase II dose-expansion study to evaluate safety, pharmacokinetics and efficacy of avapritinib in patients with metastatic gastrointestinal str

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service